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CD4+ T follicular helper (Tfh) cells provide the
required signals to B cells for germinal center reac-
tions that are necessary for long-lived antibody re-
sponses. However, it remains unclear whether there
are CD4+ memory T cells committed to the Tfh cell
lineage after antigen clearance. By using adoptive
transfer of antigen-specific memory CD4+ T cell sub-
populations in the lymphocytic choriomeningitis
virus infectionmodel, we found that there are distinct
memory CD4+ T cell populations with commitment
to either Tfh- or Th1-cell lineages. Our conclusions
are based on gene expression profiles, epigenetic
studies, and phenotypic and functional analyses.
Our findings indicate that CD4+ memory T cells
‘‘remember’’ their previous effector lineage after
antigen clearance, being poised to reacquire their
lineage-specific effector functions upon antigen
reencounter. These findings have important implica-
tions for rational vaccine design, where improving
the generation and engagement of memory Tfh cells
could be used to enhance vaccine-induced protec-
tive immunity.
INTRODUCTION
Naive pathogen-specific CD4+ T cells respond to acute infec-
tions through robust proliferation and differentiation to generate
effector cells with the capacity to provide help to the many and
diverse branches of the immune system. Following antigen
clearance, the majority of antigen-specific effector cells undergo
apoptosis, leaving behind a population of memory CD4+ T cells.
In addition to their ability to survive and undergo homeostatic
proliferation in the absence of antigen, memory T cells retain
the capacity to rapidly recall effector function, traffic to a wide
range of tissues, and exist at much higher frequencies than naivecells specific for the same antigen. These features provide the
host with a protective network of pathogen-specific memory T
helper cells that are poised to swiftly respond upon a secondary
challenge (Sallusto et al., 2010).
Naive CD4+ T cells havemultiple fates and upon activation can
develop into a variety of specialized subsets, such as T helper 1
(Th1), Th2, Th17, and regulatory T (Treg) cells. Each of these
lineages has distinct gene expression programs that are regu-
lated by specific STATS, transcription factors, and epigenetic
mechanisms (O’Shea and Paul, 2010). More recently, an addi-
tional subset known as T follicular helper (Tfh) cells has been
identified as the CD4+ T cell subset that provides help for
antibody responses. Tfh cells provide the necessary signals to
antigen-specific B cells to generate and maintain the germinal
center reaction, thus facilitating efficient class switching and
affinity maturation of antibodies, and the generation of long-lived
antibody-secreting plasma cells (Crotty, 2011). Tfh cells were
first characterized in humans by their expression of the B cell
follicle homing receptor CXCR5 (Breitfeld et al., 2000; Kim
et al., 2001; Schaerli et al., 2000), high ICOS and PD-1 expres-
sion, and the transcription factor Bcl6 (Crotty et al., 2010). Tfh
cells can localize to the B cell follicle by sensing CXCL13 through
CXCR5 (Ansel et al., 1999; Kim et al., 2001). Bcl6 has recently
been identified as a Tfh lineage regulator (Johnston et al.,
2009; Nurieva et al., 2009; Yu et al., 2009), and shares a recip-
rocal relationship with the transcriptional repressor Blimp-1,
which suppresses Tfh differentiation (Crotty et al., 2010; John-
ston et al., 2009). However, it remains unclear whether Tfh cells
possess the capacity to further differentiate into the resting
memory CD4+ T cell pool and retain their Tfh lineage commit-
ment after antigen clearance (Crotty, 2011; Fazilleau et al.,
2007; Liu et al., 2012; Lu¨thje et al., 2012; Marshall et al., 2011;
Pepper et al., 2011; Weber et al., 2012).
To address whether Tfh memory cells exist within the pool of
memory CD4+ T cells, we studied virus-specific CD4+ T cells
throughout the primary, memory, and secondary effector phases
of the immune response following acute lymphocytic choriome-
ningitis virus (LCMV) infection. We report here that a distinct
CXCR5+ subset of antigen-specific CD4+ T cells preferentially
recalled a Tfh cell secondary response following transfer andImmunity 38, 805–817, April 18, 2013 ª2013 Elsevier Inc. 805
Figure 1. Phenotypic Heterogeneity of Virus-Specific CD4+ T Cells Is Maintained during Effector and Memory Differentiation
We adoptively transferred 2 3 105 CD45.1+ LCMV-specific naive SMARTA transgenic CD4+ T cells into CD45.2+ naive recipients that were then infected with
2 3 105 PFU of LCMV Armstrong. FACS plots are gated on CD4+CD45.1+ SMARTA cells at the indicated time points relative to infection.
(A) Kinetics of splenic SMARTA CD4+ T cells.
(B) CXCR5, PD-1, ICOS, GL-7, Ly6c, and granzyme B analysis of naive, effector, and memory SMARTA CD4+ T cells.
(C) Analysis of T-bet and Bcl6 expression.
(legend continued on next page)
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a Th1 cell secondary response. Based on these findings, we pro-
pose a model in which Th1 and Tfh cells differentiate to become
Th1 and Tfh memory cells, respectively, poised to preferentially
recall their previously programmed lineage-associated gene
expression patterns and effector functions upon antigen rechal-
lenge. These findings have important implications for vaccine
design, where adjuvants and strategies that promote a higher
quantity and quality of memory Tfh cells may enable enhanced
humoral immunity following prime and boost vaccination.
RESULTS
Phenotypic Heterogeneity of Virus-SpecificCD4+ TCells
Is Maintained during Effector and Memory
Differentiation
To determine whether heterogeneity in the effector CD4+ T cell
population persists during memory development, we performed
a longitudinal analysis of Th1- and Tfh-cell phenotypic marker
expression on LCMV-specific CD4+ T cells following acute
LCMV infection. Congenically-marked (CD45.1) naive SMARTA
transgenic (Tg) CD4+ T cells specific for the LCMV GP66–77
epitope were adoptively transferred into recipient mice, and
donor SMARTA cells (CD4+CD45.1+ gated) were analyzed at
effector and memory time points following infection (Figure 1A).
We observed that approximately 45% of virus-specific effector
(day 7 postinfection) SMARTA cells expressed CXCR5 and
high amounts of PD-1 and ICOS and contained a subpopulation
of GL-7hi germinal center Tfh cells (Yusuf et al., 2010), consistent
with a Tfh phenotype (Figure 1B). Further, the majority of
CXCR5+ effector cells downregulated Ly6c expression and ex-
pressed low levels of granzyme B, while the CXCR5 effector
cells displayed higher Ly6c and granzyme B expression (Fig-
ure 1B). In addition, CXCR5+ effector SMARTA cells expressed
Bcl6 and low amounts of T-bet, whereas CXCR5 effector cells
were Bcl6 negative and expressed high amounts of T-bet (Fig-
ure 1C). Similar to LCMV-specific SMARTA Tg cells, endoge-
nous LCMV GP66–77 specific (tetramer
+) effector CD4+ T cells
in LCMV-infected B6 mice exhibited the same dichotomy of
CXCR5+ and CXCR5 cells with similar expression patterns of
PD-1, Ly6c, Bcl6, and T-bet (see Figure S1A and S1B available
online). These data demonstrate the generation of both Tfh and
Th1 virus-specific effector cells during LCMV infection, which
could be generally distinguished by Ly6c and CXCR5 expres-
sion. In agreement with this, Ly6clo SMARTA effector cells local-
ized predominantly within the B cell follicle and germinal centers,
whereas Ly6chi effector cells were generally outside of B cell
follicles and germinal centers (Figure S1F).
We observed that CXCR5+ Tfh effector cells were lower for
Psgl1 expression than CXCR5 Th1 effector cells (Figure S1C).(D) Analysis of Bcl6 and CXCR5 on effector (day 8) and memory (day 100–133) S
(E) Bcl6 MFI of CXCR5+ gated effector and memory SMARTA cells. Statisticall
unpaired Students t test.
(F) The frequency of effector and memory SMARTA cells that are CXCR5+ and CX
lymph node; mLN, mesenteric lymph node; BM, bone marrow; Liv, liver; Lung, an
n = 3 mice at each time point.
(G) Plots of CD4+CD45.1+ gated SMARTA cells with gates indicating the Ly6c+C
indicates the number of each subset in spleen following infection (nR 3 at eachThis finding was consistent with a previous report that showed
Bcl6-dependent downregulation of Psgl1 expression on Tfh
cells (Poholek et al., 2010). Another recent study also using the
LCMV infection model used the markers Psgl1 and Ly6c in com-
bination to identify effector and memory subsets of LCMV-spe-
cific CD4 T cells (Marshall et al., 2011). Their study described
the Psgl1loLy6clo effector subset as Tfh cells, the Psgl1hiLy6chi
(Tbethi) effector subset as Th1 cells, and the Psgl1hiLy6clo
effector cells as less terminally differentiated Th1 cells (Marshall
et al., 2011). However, we observed that the Psgl1loLy6clo pop-
ulation did not account for all CXCR5+ Tfh effector cells, and the
Psgl1hi-intLy6clo effector population was composed of a similar
proportion of both CXCR5+ Tfh and CXCR5 Th1 effector cells
(Figures S1D and S1E). Thus, Psgl1 used in combination with
Ly6c does not clearly distinguish between Tfh and Th1 lineage
effector cells (Figures S1D and S1E). Furthermore, unlike at
effector time points, the Psgl1hi-intLy6clo memory subset had
higher CXCR5 expression than the Psgl1loLy6clo memory subset
(Figures S1D and S1E), indicating that the combination of Psgl1
and Ly6c markers is not useful for subsetting cells with the most
Tfh-like qualities at both effector and memory time points.
Interestingly, whereas PD-1, ICOS, GL-7, and Bcl6 expression
were absent on virus-specific memory cells (day 105), approxi-
mately 40% of SMARTA cells maintained CXCR5 expression,
albeit at decreased surface expression relative to effector Tfh
cells (Figures 1B and 1C), a pattern which was also observed
in endogenous GP66–77 tetramer
+ memory cells (Figure S1B).
Antigen-specific CXCR5+ memory cells were also observed in
the blood but had reduced Bcl6 expression relative to their
effector counterparts (Figures 1D and 1E). CXCR5+ effector cells
were abundant in blood and secondary lymphoid organs;
however, unlike CXCR5 Th1 effector cells, CXCR5+ cells were
almost entirely excluded from nonlymphoid tissues such as
lung, liver, and IEL (Figure 1F). As expected, the total number
of memory SMARTA CD4+ T cells in each tissue was reduced
compared to the effector stage (Table S1), and coincided with
a similar pattern in the tissue distribution of CXCR5+ and
CXCR5 cells at the memory time point (Figure 1F). Thus, anti-
gen-specific CXCR5+ cells are mostly found in lymphoid organs
and excluded from nonlymphoid tissues at both effector and
memory time points.
At memory time points, CXCR5+ memory cells fall into two
subsets: Ly6clo and Ly6cint. Following the contraction phase of
antigen-specific Th1 and Tfh effector cells, the CXCR5Ly6chi,
CXCR5+Ly6clo, and CXCR5+Ly6cint CD4+ SMARTA subsets
are maintained into the memory phase in stable numbers (Fig-
ure 1G). Together, these data show that distinct effector T helper
subsets (Th1 and Tfh) develop from a clonal population of virus-
specific cells and suggest that these populations are maintained
as distinct lineages within the heterogeneous memory pool.MARTA cells in blood and spleen.
y significant p values are shown and were determined by using a two-tailed
CR5 in the following tissues are as follows: Spl, spleen; Bl, blood; iLN, inguinal
d IEL, intestinal intraepithelial lymphocytes. Graphs show the mean and SEM.
XCR5 (blue), CXCR5+Ly6clo (red), and CXCR5+Ly6cint (green) subsets. Chart
time point). Error bars represent the SEM. See also Figure S1 and Table S1.
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Relationships between Tfh Effector and Memory Cells
and between Th1 Effector and Memory Cells
To examine potential relationships between effector and
memory cells of the Tfh and Th1 cell lineages, we performed
gene expression profiling of sorted CXCR5Ly6chi, CXCR5+
Ly6clo, and CXCR5+Ly6cint SMARTA subsets at effector and
memory time points. These analyses revealed many genes that
were commonly regulated between the Th1 effector and
CXCR5Ly6chi Th1-like memory cells and that distinguished
them from Tfh effector and CXCR5+ Tfh-like memory cells (Fig-
ure 2A). Similarly, many genes that were expressed in Tfh
effector cells were also expressed in the CXCR5+Ly6clo and
CXCR5+Ly6cint memory subsets, whereas expression of these
same genes was downregulated in Th1 effector and memory
cells (Figure 2A). We performed gene set enrichment analysis
(GSEA) of the microarray data sets to further evaluate the degree
that gene expression patterns were shared between these
various subsets. These analyses revealed that gene expression
patterns by CXCR5Ly6chi Th1 memory cells were enriched in
the effector Th1 cell expression profile (Enrichment Score:
0.78) (Figure S2A), whereas the upregulated gene set in
CXCR5+Ly6clo memory cells was enriched in the Tfh effector
profile (Enrichment score: 0.70) (Figure S2B).
Expression analysis of specific genes by CXCR5Ly6chi
memory cells revealed a similar pattern as the CXCR5Ly6chi
Th1 effector subset, showing higher levels of Tbx21 (T-bet),
Prdm1 (Blimp-1), and Ly6c and no Cxcr5 expression compared
to the CXCR5+Ly6clo memory subset (Figures 2B and 2C). In
contrast, CXCR5+Ly6clo memory cells maintainedCxcr5 expres-
sion and intermediate levels of T-bet gene expression and did
not express Prdm1 (Blimp-1), a pattern similar to CXCR5+Ly6clo
Tfh effector cells (Figures 2B and 2C). Furthermore, Bcl6 tran-
script levels remained slightly upregulated in the CXCR5+Ly6clo
memory cells (relative to naive cells). Similar patterns ofBcl6 and
Prdm1 (Blimp-1) gene expression were confirmed by real-time
PCR (Figure S2C). Together, these data indicate that the gene
expression patterns of Cxcr5 and these transcription factors
that define the Th1 and Tfh lineages in CD4+ T cells are main-
tained (although at lower expression amounts compared to
effector cells) in subsets of resting memory cells. In addition,
we found that gene expression of the transcription factor Plagl1
(Abdollahi, 2007), a genewith no previously reported role in CD4+
T cell differentiation, distinguished between the Th1 and Tfh cell
populations at both the effector and memory phases of the im-
mune response (Figure 2C).
We next examined the expression of genes that encode cyto-
kine and chemokine receptors, costimulatory and inhibitoryFigure 2. Transcriptional Profiling Suggests a Lineage Relationship be
Memory Cells
Microarray analysis of CD4+ SMARTA CXCR5Ly6chi (blue), CXCR5+Ly6clo (red),
postinfection) and memory time points (day 68–147 p.i.).
(A) The 30 most upregulated and 30 most downregulated genes in the day 6 Ly6h
were identified and their expression in all subsets at effector and memory stages
(B–F) Expression of select genes as determined by microarray analysis, includi
receptors, (E) cytokines and cytotoxic effector molecules, and (F) costimulatory an
CD4+ T cells. Bars show the average value for each indicated population; effector
(n = 4), memory CXCR5+Ly6clo (n = 4), and memory CXCR5+Ly6cint (n = 3). Seereceptors, cytokines, and cytotoxic molecules. Expression of
Th1-associated genes including Il-2ra, Ifng, Ccl5, and Gzmb
were more highly expressed in the CXCR5Ly6chi compared to
the CXCR5+Ly6clo and CXCR5+Ly6cint memory populations
(Figures 2D and 2E). In contrast, genes involved in Tfh function
and differentiation (Crotty, 2011), including Cxcr5, Cxcr4, Il6ra,
Pdcd1 (PD-1), Cd200, and Sh2d1a (SAP), were more highly
expressed in memory CXCR5+Ly6clo compared with memory
CXCR5Ly6chi cells (Figures 2B and 2D–2F; Figure S2D). Of
note, several genes related to the cytotoxic potential of effector
cells, including those that code for granzyme B and other gran-
zymes, perforin, and Fas ligand were preferentially increased in
the CXCR5Ly6chi SMARTA effector cells (Figure 2E). Interest-
ingly, the CXCR5+Ly6cint memory population in many cases dis-
played a gene expression pattern that was intermediate between
that of the CXCR5Ly6chi and CXCR5+Ly6clo memory popula-
tions (Cxcr5, Bcl6, Prdm1, Tbx21, Plagl1, Ccr6, Ccl5, Prf1, and
Ctla2a), suggesting more heterogeneity and/or lineage pluripo-
tency within this population (Figures 2B–2F). Collectively, these
data show that memory CXCR5Ly6chi and CXCR5+Ly6clo
CD4+ T cell populations are enriched for Th1 and Tfh associated
gene expression programs, respectively, and may thus be
poised to preferentially recall distinct T helper effector responses
upon antigen re-exposure.
Th1 and Tfh Memory CD4+ T Cells Are Committed for
Recall of Lineage-Specific Functions
To determine whether the generation of secondary Th1 versus
Tfh effector CD4+ T cells arise from these distinct memory pop-
ulations, we sorted memory SMARTA cells into CXCR5Ly6chi,
CXCR5+Ly6clo, and CXCR5+Ly6cint subsets and transferred
them into naive recipient mice, then challenged these mice
with LCMV Armstrong (acute infection) (Figure 3A). The expan-
sion of the CXCR5Ly6chi and CXCR5+Ly6clo responding
memory populations was relatively similar in the spleen 7 days
postinfection (between 62- and 69-fold, assuming a 10%
take in the spleen following adoptive transfer), whereas the
CXCR5+Ly6cint subset expanded more extensively (approxi-
mately 248-fold) (Figure 3B). Interestingly, CXCR5+Ly6clo and
CXCR5+Ly6cint memory SMARTA cells preferentially recalled a
Tfh phenotype following rechallenge, becoming mostly
CXCR5+ effector cells, whereas the majority of secondary effec-
tors derived from the transferred CXCR5Ly6chi memory cells
remained Ly6chi and CXCR5 (Figure 3C). Furthermore, both
the CXCR5+Ly6clo and CXCR5+Ly6cint memory cells gave rise
to significantly increased frequencies of CXCR5+ ICOShi Tfh
effector cells and contained significantly more GL-7+ germinal
center Tfh cells relative to those derived from CXCR5Ly6chitween Tfh Effector and Memory Cells and between Th1 Effector and
and CXCR5+Ly6cint (green) subsets sorted from chimeric mice at effector (day 6
iCXCR5 (Th1) relative to the day 6 CXCR5+Ly6clo (Tfh) SMARTA CD4+ T cells
is shown as a heatmap.
ng (B) Cxcr5 and Ly6c, (C) transcription factors, (D) cytokine and chemokine
d inhibitory receptors. Data are shown as fold change relative to naive SMARTA
CXCR5Ly6chi (n = 2), effector CXCR5+Ly6clo (n = 2), memory CXCR5Ly6chi
also Figure S2.
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Figure 3. Th1 and Tfh Memory CD4+ T Cells Are Committed for Recall of Lineage-Specific Functions
CD45.1 congenically marked CXCR5Ly6chi (blue), CXCR5+Ly6clo (red), and CXCR5+Ly6cint (green) memory CD4+ subsets (between days 56 and 101 post-
infection) were FACS purified to >97%. We adoptively transferred 8 3 103 sorted cells into naive CD45.2 recipients, and recipient mice were then infected with
LCMV Armstrong 16–20 hr later. In (C)–(I), the phenotype and function of transferred SMARTA cells were analyzed 7 days postinfection.
(A) Representative postsort analysis of memory SMARTA subsets and cartoon of experimental setup.
(B) Absolute number of transferred CD4+ CD45.1+ SMARTA splenocytes 7 days following rechallenge with LCMV. The relative fold increase of each population,
assuming a 10% take of transferred SMARTA cells, is shown above each bar.
(C) Representative CXCR5 and Ly6c analysis.
(D) Chart shows the percent of transferred SMARTA cells that are CXCR5+ICOS+ Tfh cells.
(E) The percent of SMARTA cells that are CXCR5+GL-7+ germinal center Tfh cells.
(F) Bcl6 MFI of SMARTA cells.
(G) T-bet MFI of SMARTA cells.
(H) Chart shows the percent of B220+ gated splenic B cells that are Fas+PNA+ germinal center B cells. Data were combined from two experiments.
(I) Chart shows the percent of transferred SMARTA cells that are CXCR5granzymeBhi cells. Data in (B), (D), (E), and (I) are combined from four independent
experiments for a total of n = 11–14 mice per group. Data in (F) and (G) were from a single experiment (n = 3 per group) and were representative of two to four
independent experiments. Statistically significant p values are shown and were determined using a two-tailed unpaired Student’s t test. Error bars represent the
SEM. See also Figure S3.
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effector cells derived from the CXCR5+Ly6clo and CXCR5+-
Ly6cint memory populations displayed significantly higher810 Immunity 38, 805–817, April 18, 2013 ª2013 Elsevier Inc.Bcl6+ and lower T-bet expression relative to those derived
from CXCR5Ly6chi memory CD4+ T cells (Figures 3F and 3G;
Figure S3D). Importantly, the transfer of CXCR5+ memory
Immunity
Defining Memory CD4+ T Follicular Helper CellsSMARTA cells promoted the rapid appearance (within 7 days
postinfection) of Fas+PNA+ germinal center B cells compared
to the transfer of CXCR5Ly6chi memory cells (Figure 3H).
Together, these data indicate that CXCR5+ memory cells are
biased toward a Tfh cell recall response.
To further define the characteristics of CXCR5Ly6chi,
CXCR5+Ly6clo, CXCR5+Ly6cint memory SMARTA cells, we eval-
uated their capacity to generate a Th1 cell secondary response.
Effector cells derived from CXCR5Ly6chi memory cells had
significantly increased levels of T-bet expression (Figure 3G; Fig-
ure S3D). In addition, themajority of these cells wasCXCR5 and
had an enhanced capacity for granzymeB expression in both the
spleen (Figure 3I; Figure S3A) and in lung (Figure S3G). In
contrast, although the majority of effector cells generated from
CXCR5+Ly6clo and CXCR5+Ly6cint subsets were CXCR5+, those
that becameCXCR5 cells had a diminished capacity to express
granzyme B (Figure 3I; Figure S3A), even in the lung, a nonlym-
phoid tissue that enriches for Th1 effector cells (Figure S3G).
Thus, CXCR5Ly6chi Th1 memory cells efficiently produce Th1
effector cells following antigen challenge, whereas CXCR5+
Ly6clo and CXCR5+Ly6cint Tfh memory cells have a cell-intrinsic
restriction that limits their capacity to express granzyme B. In
addition, significantly fewer effector cells derived from CXCR5+
Ly6clo and CXCR5+Ly6cint Tfh subsets (compared with those
from CXCR5Ly6chi memory cells) produced IFN-g and had
lower expression of this cytokine, being more consistent with
the IFN-g expression levels of Tfh cells (Figure S3H).
To determine whether the CXCR5Ly6chi, CXCR5+Ly6clo,
and CXCR5+Ly6cint memory subsets are committed to their
respective Th1 and Tfh cell lineages, we compared their re-
sponses to the primary effector response generated from
uncommitted (naive) SMARTA CD4+ T cells. CXCR5Ly6chi
memory cells exhibited Th1 lineage commitment, producing a
significantly higher frequency of granzyme B+ and IFN-g+
effector cells, whereas CXCR5+Ly6clo and CXCR5+Ly6cint
memory cells generated a significantly higher frequency of
Tfh cells and fewer Th1-like cells compared to the primary
effector response (Figures S3B, S3F, and S3H). We thus
conclude that the CXCR5Ly6chi subset are Th1 memory cells,
and that both CXCR5+Ly6clo and CXCR5+Ly6cint subsets are
Tfh memory cells.
To determine whether Th1 and Tfh memory cells maintain their
respective lineage biases in the absence of antigen, sorted Th1
memory and Tfh memory SMARTA cells were adoptively trans-
ferred into naive recipient mice and rested for 28 days before
rechallenging these recipients with acute LCMV infection
(Figure 4A). Consistent with our previous results (Figure 3),
CXCR5+ Tfh memory cells preferentially generated Tfh effector
cells (Figure 4B) and GL7+ GC Tfh cells (Figure 4C). Furthermore,
these effector cells expressed significantly more Bcl6 and less
T-bet (Figures 4D and 4E). The CXCR5 effector cells that
were generated from the CXCR5+ Tfh memory population also
had significantly higher ICOS expression (Figure 4F) and ex-
hibited an impairment for granzyme B expression compared
with those generated from CXCR5 Th1 memory cells (Figures
4G and 4H). After challenge, memory Th1 cells generated Th1
effector cells with high T-bet and granzyme B expression (Fig-
ure 4). Thus, the capacity of CXCR5 Th1 and CXCR5+ Tfh
memory cells to recall their lineage-specific responses is notdependent on the continued presence of antigen during the
maintenance phase of memory differentiation.
Cells with a Central Memory Phenotype Exist within the
Tfh and Th1 Memory Populations
We next evaluated whether a central memory phenotype (by
CD62L and CCR7 expression) was associated with CXCR5
expression by memory cells. As expected, within 5 days post-
LCMV infection, SMARTA cells had downregulated CD62L,
followed by the gradual re-expression by memory cells (Fig-
ure S4A). Compared to day 8 effector cells that were almost
entirely CD62L and had downregulated CCR7, all memory
SMARTA cells expressed some surface CD62L andCCR7, being
either low or intermediate for each of these surface markers
(Figure S4B). Further analysis showed that cells expressing
high levels of surface CD62L and CCR7 existed within both
CXCR5+ and CXCR5 memory populations (Figure S4C). Thus,
cells of a central memory phenotype exist within both Th1
and Tfh memory populations (Figure S4C). To determine
whether CD62L+ compared to CD62L Th1 and Tfh memory
cells exhibited different T helper lineage recall potential following
rechallenge, we sorted CD62L and CD62L+ subsets of CXCR5+
and CXCR5 memory cells, transferred them into congenic
recipient mice, and challenged these mice with LCMV (Fig-
ure S4D). Both CD62L+ and CD62L Th1memory cells preferen-
tially generated CXCR5 Th1 effector cells to similar degrees,
whereas CXCR5+ CD62L and CD62L+ memory cells generated
substantial Tfh effector cells (Figure S4E). These data suggest
that whereas CD62L+ central memory phenotype cells exist
within both Th1 and Tfh memory populations, the CXCR5 Th1
memory and CXCR5+ Tfh memory cells maintain and recall their
relative lineage-associated phenotypes regardless of CD62L
expression.
Tfh Memory CD4+ T Cells Recall a Tfh-like Response
Even in B Cell Deficient Recipient Mice
Interaction with cognate B cells and continued ICOS signaling
are required for stabilizing the Tfh phenotype and the mainte-
nance of primary effector Tfh cells (Crotty, 2011). We next
evaluated whether memory Tfh cells could recall aspects of the
Tfh effector program when reactivated in the absence of B cells
by transferring them into B cell deficient recipients prior to
LCMV infection (Figure 5A). As expected, GL-7+ (germinal center
phenotype) Tfh-like effector cells were nearly undetectable in
B cell deficient recipient mice following infection (Figure S5).
Similar to what has been previously reported (Johnston et al.,
2009), naive SMARTA cells transferred into B cell deficient
mice generated a significantly reduced frequency of CXCR5+
Tfh-like effector cells at day 7 postinfection, which continued
to decrease to less than 10 percent by day 10 (Figures 5B and
5C). In contrast, approximately 30 percent of effectors derived
from CXCR5+Ly6clo and CXCR5+Ly6cint memory cells were
CXCR5+ Tfh-like cells at day 7, and surprisingly this frequency
was maintained at approximately 35%–45% at day 10 in the
absence of B cells (Figures 5B and 5C). Thus, compared to
naive CD4+ T cells, CXCR5+Ly6clo and CXCR5+Ly6cint memory
cells have a cell-intrinsic capacity to recall and maintain
aspects of the Tfh phenotype such as CXCR5 expression,
even in the absence of B cells. These results clearly demonstrateImmunity 38, 805–817, April 18, 2013 ª2013 Elsevier Inc. 811
Figure 4. Lineage Commitment of Th1 and Tfh Memory Subsets Is Maintained in the Absence of Antigen
CD45.1 congenically marked CXCR5Ly6chi (blue) and CXCR5+ (red) memory SMARTA CD4+ T cell subsets 34 days postinfection were FACS purified to >97%.
We adoptively transferred 83 104 purified cells into naive CD45.2 recipients. Twenty-eight days following cell transfer, naive recipients were infected with 23 105
p.f.u. LCMV Armstrong 16–20 hr later. The phenotype (B–H) of transferred CD4+CD45.1+ gated SMARTA cells was analyzed 7 days postinfection.
(A) Cartoon of experimental setup.
(B) CXCR5 and ICOS analysis. Chart shows the percent of SMARTA cells that are CXCR5+ICOS+ Tfh cells.
(C) The percent of transferred SMARTA cells that are CXCR5+GL-7+ germinal center Tfh cells.
(D) Bcl6 MFI of SMARTA cells.
(E) T-bet MFI of SMARTA cells.
(F) ICOS MFI on CXCR5 gated effector SMARTA cells 7 days postrechallenge.
(G) Chart shows the percent of transferred SMARTA cells that are CXCR5granzyme Bhi cells 7 days postrechallenge.
(H) Chart shows the granzyme B MFI of SMARTA cells in lung 7 days postrechallenge. For (A)–(H), CXCR5Ly6chi (n = 4) and CXCR5+ (n = 5). Statistically
significant p values of <0.05 are indicated and were determined by using a two-tailed unpaired Student’s t test. See also Figure S4.
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Tfh lineage.
Epigenetic Modifications of the Granzyme B Locus
Distinguish Tfh Memory from Th1 Memory CD4+ T Cells
Wehave shown that granzymeB expression is strikingly different
between Th1 and Tfh cells at an effector time point (Figures 1
and 2; Figure S3), and is most efficiently re-expressed by
CXCR5Ly6chi Th1 memory cells following viral rechallenge
(Figure 3; Figure S3). We next tested whether the difference in
granzyme B expression occurs very early in CD4+ lineage differ-
entiation following activation of naive CD4+ T cells. Rapidly
following activation, naive SMARTA cells had diverged into
distinct granzyme B+ and granzyme B populations, even in
undivided cells, that persisted as separate populations while
undergoing proliferation during the first 4 days of LCMV infection812 Immunity 38, 805–817, April 18, 2013 ª2013 Elsevier Inc.(Figure 6A). Granzyme B expression correlated with high T-bet
expression as early as day 2 postinfection (Figure 6B), demon-
strating that very early following activation (within only a few
rounds of cell division), high granzyme B expression is restricted
to Th1 cells. Day 5 CXCR5 Th1 cells expressed high levels
of granzyme B, while expression was mostly diminished by
day 9, and absent in CXCR5 SMARTAmemory cells (Figure 6C;
Figure 1B).
The bimodal distribution of granzyme B expression during
effector CD4+ T cell differentiation, in conjunction with our obser-
vation that granzyme B transcript is significantly upregulated
only in CD4+ Th1 effector cells, suggests that CD4+ Tfh cells
retain a transcriptional regulatory mechanism for repressing
granzyme B expression. Epigenetic modifications serve as a
mechanism for a dividing cell population to ‘‘remember’’ the
transcriptional status of the parental cell population (Reik,
Figure 5. Tfh Memory CD4+ T Cells Recall a Tfh-
like Response Even in B Cell Deficient Recipient
Mice
CD45.1 congenically marked CXCR5Ly6chi (blue),
CXCR5+Ly6clo (red), and CXCR5+Ly6cint (green)
SMARTA memory CD4+ T cell subsets (days 68 and 88
postinfection), and naive SMARTA cells sorted as
CD44lo (black) were FACS purified to >97%. We adop-
tively transferred 8 3 103 purified cells into naive
CD45.2+ WT and mMT (B cell-deficient) B6 recipients,
and recipient mice were then infected with LCMV Arm-
strong. The phenotype and function of SMARTA cells
were analyzed 7 and 10 days postinfection.
(A) Cartoon of experimental setup.
(B) Representative CXCR5 and ICOS analyses of CD4+
CD45.1+ gated SMARTA cells 7 and 10 days post-
infection.
(C) Charts show the frequency of SMARTA cells that are
CXCR5+ICOS+ Tfh-like cells in B cell-deficient mice at
each time point following infection with LCMV. Data for
day 7 were combined from two independent experi-
ments (n = 7 per experimental group) and day 10 were
from one experiment (n = 3 per group). Statistically sig-
nificant p values were determined using a two-tailed
unpaired Student’s t test (***p < 0.001; **p < 0.01; *p <
0.05). See also Figure S5.
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expression is coupled to repressive epigenetic modifications in
effector andmemory Tfh cells, we analyzed the DNAmethylation
status in theGzmb transcriptional regulatory region in naive, Th1Immunity 38,and Tfh effector, and Th1 and Tfh memory
cells following LCMV infection. We found that
the Gzmb locus becomes unmethylated
exclusively in Th1 effector cells and remains
unmethylated in Th1 memory cells, whereas
CD4+ Tfh cells retain the naive DNA methyl-
ation program at the Gzmb locus throughout
effector and memory differentiation (Fig-
ure 6D). Thus, our data show that methylation
of the Gzmb locus can be used to distinguish
CD4+ Th1 cells from Tfh cells and further
confirm the lineage relationship between
effector and memory Tfh cells. Furthermore,
the repression of cytotoxic molecule expres-
sion such as granzyme B and perforin
(Figure 2E) in Tfh cellsmay be essential for pre-
venting the unwanted destruction of antigen-
presenting B cells.
We also examined the methylation status of
several other loci in Th1 and Tfh lineage cells.
Surprisingly, the Il21 locus was demethylated
in both Tfh and Th1 cells and remained unme-
thylated in both memory populations (Fig-
ure 6E). Although IL-21 is characterized as a
cytokine critical for Tfh function, Th1 cells
can also express it, albeit with reduced tran-
script levels (Figure 2) (Fahey et al., 2011;
Spolski and Leonard, 2010). Similarly, the
Ifng locus became demethylated in both Tfhand Th1 cells and remained unmethylated in memory cells (Fig-
ure 6E). These data suggest that both Th1 and Tfh memory CD4+
T cells transitioned through an effector stage of differentiation,
and that the Ifng and Il21 loci may be similarly poised for potential805–817, April 18, 2013 ª2013 Elsevier Inc. 813
Figure 6. Epigenetic Modifications of the
Granzyme B Locus Distinguish Tfh Memory
from Th1 Memory CD4+ T Cells
(A and B) We transferred 1–2 3 106 CFSE-labeled
SMARTA cells into host mice and infected 1 day
later. (A) Plots show granzyme B expression and
CFSE dilution analysis of SMARTA cells at the
indicated time points postinfection. (B) Plot shows
granzyme B and T-bet expression analysis of
SMARTA cells 2 days postinfection.
(C–E) We transferred 2 3 105 SMARTA cells into
host mice that were infected 1 day later. (C) Flow
cytometry plots show granzyme B and CXCR5
expression of SMARTA cells at the indicated time
points postinfection. (D and E) Sorted antigen-
specific SMARTA CD4+ Tfh and Th1 cells were
isolated from the spleen and purified by FACS
at naive, effector, and memory stages of dif-
ferentiation. Tfh subsets were defined as CXCR5+
Ly6clo, whereas Th1 subsets were defined as
CXCR5Ly6chi. DNA methylation status of (D)
Gzmb and (E) Il21, Ifng, and Pdcd1 loci were
determined by bisulfite sequencing the genomic
DNA from the purified cells. Each horizontal line
corresponds to the sequence of an individual
clone. Filled circles represent methylated cyto-
sine. Open circles represent nonmethylated
cytosine. Representative dot plots from one
complete data set are shown. Data are represen-
tative of at least three indepentently isolated
populations of naive (uninfected CD44lo), effector
(days 5–10), and memory (days 49–101) SMARTA
cells. See also Figure S6.
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tigen reencounter. The Pdcd1 (PD-1) locus was demethylated
following infection in both Tfh and Th1 cells, although there
may be slightly more methylation in Th1 compared to Tfh mem-
ory cells (Figure 6E).
DISCUSSION
There is considerable interest in understanding the genera-
tion of CD4+ Tfh memory cells. However, this topic remains
controversial because several recent studies have reported
different conclusions regarding the existence of a committed
population of memory Tfh cells (Liu et al., 2012; Lu¨thje et al.,
2012; MacLeod et al., 2011; Marshall et al., 2011; Pepper
et al., 2011; Weber et al., 2012). In this study, by using the mouse814 Immunity 38, 805–817, April 18, 2013 ª2013 Elsevier Inc.model of acute LCMV infection, we show
that there are distinct populations of vi-
rus-specific memory CD4+ T cells with
commitment to either the Tfh or Th1 cell
lineages. Our findings indicate that anti-
gen-specific memory CD4+ T cells that
maintain CXCR5 expression are biased
toward the recall of a Tfh effector
response, whereas CXCR5Ly6chi mem-
ory cells efficiently recall Th1 effector
cells. These findings are consistent with
a model in which the concomitant gener-ation of a pool of resting memory Th1 or Tfh cells arise from the
corresponding effector Th1 and Tfh cells, respectively. Commit-
ment of memory CD4+ T cells to Th1 or Tfh lineages provides
cells that are poised for the lineage-specific reexpression of
effector molecules upon reexposure to antigen (see model in
Figure S6).
In contrast to our findings, by using a Listeria monocytogenes
infection model, Pepper et al. suggested that memory CD4+
T cells that express CXCR5 and CCR7 are a central memory
population with a capacity to fully reconstitute Th1 and Tfh
effector populations (Pepper et al., 2011). Whereas our study
also shows that there is more pluripotency among the Tfh
compared to Th1memory population, there is still clear evidence
of Tfh lineage commitment in CXCR5+memory CD4+ T cells. The
differing results seen in recall responses from CXCR5+ memory
Immunity
Defining Memory CD4+ T Follicular Helper Cellscells between our study and the report by Pepper et al. may
result from the different infection systems used (LCMV versus
Listeria monocytogenes). The report by Pepper et al. suggests
that Tfh cells do not enter the memory pool based on the
absence of CXCR5hiPD-1hi cells at memory time points (Pepper
et al., 2011). In our study, LCMV-specific CD4+ T cells (both
SMARTA and endogenous GP66–77 tetramer
+) at memory time
points show decreased CXCR5 and relatively absent PD-1,
ICOS, and Bcl6 expression levels by FACS staining. We interpret
this observation (the lack of CXCR5hiPD-1hi memory cells) to
signify that activation molecules such as PD-1 (and to some
extent CXCR5) are downregulated onmemory Tfh cells following
antigen clearance, rather than indicate the disappearance of Tfh
lineage cells altogether from cells entering the memory pool.
A recent study by Lu¨thje et al. using an Il21 GFP reporter sys-
tem showed that both GFP+ and GFP subsets of CXCR5+ Tfh
cells efficiently enter the memory pool of CD4+ T cells following
adoptive transfer. In contrast with our observations, they
observed a higher frequency of CXCR5 effectors generated
from Tfh-derived memory cells following influenza rechallenge
(Lu¨thje et al., 2012). Clear interpretation of their study is limited
by the lack of analysis of antigen-specific cells at effector versus
memory and recall time points (either by MHC tetramer staining
or by using TCR transgenic cells). Their study also showed that
the majority of GFP+ (Il21+) effector cells were CXCR5+ Tfh
effector cells (Lu¨thje et al., 2012). Our data show that both Tfh
and Th1 effector cells express Il21 following LCMV infection
and that the Il21 locus becomes demethylated in both Tfh and
Th1 effector subsets. Therefore, IL-21 expression in itself is
not a clear universal indicator of T helper lineage. While our
data indicate that some CXCR5+Ly6clo and CXCR5+Ly6cint
memory cells become CXCR5 negative following reactivation,
we observed that such CXCR5 (Th1-like) effector cells do not
express granzyme B to the same extent as secondary effector
cells derived from Th1 memory cells. Our findings suggest that
although there is some degree of heterogeneity and/or plasticity
within the Tfh (CXCR5+Ly6clo and CXCR5+Ly6cint) memory
population, these cells do not yield secondary effector cells
with the same capacity for Th1 cell function as memory Th1
(CXCR5Ly6chi) cells.
Several observations within our study clearly show that
memory CD4+ T cells with commitment to the Tfh lineage exist
within the memory pool following acute LCMV infection. First,
the Tfh and Th1 cell lineage dichotomy that is established very
early following LCMV infection based on both CXCR5 surface
expression and the restriction of the capacity for granzyme B
expression can be tracked into the memory pool. Indeed, similar
to their effector precursors that do not express granzyme B,
CXCR5+ memory cells carry repressive DNA methylation marks
at theGzmb locus, and the CXCR5minority cell population that
emerges from the CXCR5+memory cells following reexposure to
antigen shows a delayed or impaired ability to express granzyme
B. It has been shown that maintenance of repressive DNA
methylation programs at the Il4 and Foxp3 loci are essential for
preventing aberrant expression of these molecules in non-Th2
and non-Treg CD4+ T cell lineages, respectively (Josefowicz
et al., 2009; Makar et al., 2003). Thus, the maintenance of DNA
methylation at the Gzmb locus (and other Th1-specific loci) in
Tfh memory cells may reinforce their Tfh lineage commitmentby repressing genes used by Th1 lineage cells (Wilson et al.,
2009). Therefore, differential DNAmethylation at theGzmb locus
can be used as an additional criterion for distinguishing CD4+ Tfh
memory from Th1 memory cells. Second, compared to the
primary response generated from uncommitted naive CD4+
T cells of the identical TCR specificity (SMARTA transgenic),
CXCR5+ Tfh memory cells are more biased toward generating
Tfh cells. Third, transfer experiments to B cell deficient mice
demonstrate that a large fraction of memory CXCR5+ Tfh cells
have acquired cell-intrinsic programs that allow them to recapit-
ulate portions of the Tfh phenotype (including CXCR5 expres-
sion) following reactivation in the absence of bidirectional signals
fromB cells that are required for the generation andmaintenance
of primary effector Tfh cells.
In agreement with our findings, several recent reports provide
evidence supporting the existence of memory Tfh cells. Marshall
et al. observed that a subset of memory cells with similar pheno-
typic features as Tfh cells existed within the memory cell pool
(Marshall et al., 2011). MacLeod et al. demonstrated that
CXCR5+ memory cells enhance the kinetics of B cell expansion
and class switching, and suggested that such CXCR5 expres-
sion on memory cells promotes migration to areas where
encounter with cognate B cells can occur following reintroduc-
tion of antigen (MacLeod et al., 2011). Similarly, findings by Liu
et al. suggest that effector Tfh cells enter the memory T cell
pool and retain their preference for recall of Tfh cells; however,
only very early memory time points were examined (Liu et al.,
2012). Another study suggested that rechallenge of memory
cells derived from adoptively transferred Tfh effector cells ex-
hibited a Tfh phenotype 2.5 days after reimmunization; however,
this phenotype was diminished 6 days postreactivation (Weber
et al., 2012). Morita et al. reported that CXCR5+CD4+ T cells
found in human blood are functional counterparts to Tfh cells
found in lymphoid organs and suggest that these may be
memory Tfh cells (Morita et al., 2011).
The repression of cytotoxic potential appears to be a hallmark
of Tfh cells, and expression of key cytolytic molecules such as
granzyme B and perforin was inhibited in Tfh but not Th1 effector
cells. Together, these data suggest that Tfh differentiation is
coupled to the restriction in cytotoxic potential by preventing
expression of Th1 cell-related killing apparatus components.
The epigenetic repression of cytotoxic molecules by Tfh cells
may be essential to prevent the unwanted destruction of anti-
gen-presenting germinal center B cells, which rely on cell-con-
tact-dependent interactions (including CD40L and SAP) with
Tfh cells for essential signals (Cannons et al., 2010; Crotty
et al., 2003, Crotty, 2011; Qi et al., 2008).
Our findings demonstrate that acute LCMV infection induces a
strikingly balanced response of both Tfh and Th1 effector CD4+
T cells and robust long-lived memory populations for both of
these lineages. This raises the question as to whether such Tfh
and Th1 balance and memory generation is achieved by other
viral infections, vaccine vectors, and protein immunization stra-
tegies. In addition, balancing the generation of Tfh memory
and other lineages of CD4+ memory T cells may be essential
for providing secondary responses that provide both optimal
CD4+ T cell help for antibody responses, as well as CD4+
T cells with effector function. Thus, future studies are needed
to determine how different adjuvants, inflammatory cytokines,Immunity 38, 805–817, April 18, 2013 ª2013 Elsevier Inc. 815
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antigen-presenting cells can be used to specifically induce either
Tfh or Th1 memory cells.
The majority of our successful vaccines rely on neutralizing
antibody and long-lived humoral responses for protective immu-
nity (Plotkin et al., 2013). Gaining a better understanding of the
development, function, and contribution of Tfh memory cells
within the context of prime and boost vaccination and pathogen
challenge will provide avenues for rational vaccine design
(D’Argenio and Wilson, 2010). Developing effective vaccines
for pathogens such as HIV and malaria will likely require the
generation of high-titer broadly neutralizing antibody responses
(Burton et al., 2012). Similarly, efforts to develop universal
influenza vaccines by targeting conserved epitopes (Sette and
Rappuoli, 2010) may possibly be improved by optimally inducing
memory Tfh cells. It is likely that vaccine strategies that fail to
induce the generation of primary Tfh cells will subsequently leave
a gap in the pool of antigen-specificmemory CD4+ T cells, result-
ing in suboptimal boosting of antibody responses. Conversely,
immunogens, adjuvants, or strategies that promote robust Tfh
responses and drive commitment and maintenance of high
numbers of antigen-specific memory Tfh cells may enhance
the quality and/or quantity of antibody production following anti-
gen boost or pathogen encounter. Thus, it is critical to design
rational prime and boost strategies for optimal generation of
Tfh memory cells.
EXPERIMENTAL PROCEDURES
Mice and Adoptive Transfers
Congenically marked (CD45.1) CD4+ T cell splenocytes specific to the
GP66–77 epitope of LCMV obtained from naive SMARTA TCR transgenic
mice (Oxenius et al., 1998) were intravenously transferred into naive
C57BL/6 (CD45.2) mice (Jackson Laboratory, Bell Harbor, ME). In order to
generate SMARTA chimeric mice with a high number of memory SMARTA
cells, thus facilitating memory cell isolation for adoptive transfer studies, we
transferred 2 3 105 naive SMARTA CD4+ T cells. Approximately 24 hr post-
transfer, chimeric mice were infected intraperitoneally (i.p.) with 2 3 105 PFU
of LCMV Armstrong. For adoptive transfer of memory SMARTA cells, CD4+
splenocytes from chimeric mice (day 56–101 postinfection) were enriched by
using a MACS CD4+ T cell Isolation Kit II (Miltenyi). Enriched CD4+ T cells
were stained and sorted to isolate CD45.2 (CD45.1 SMARTA) memory
subsets based on CXCR5, Ly6c, or CD62L to greater than 98% purity. For
rechallenge experiments, 8 3 103 sorted memory (or naive) SMARTA cells
were adoptively transferred into naive C57BL/6 mice (CD45.2) or B cell-
deficient mMT mice that were subsequently infected 24 hr later with 2 3 105
PFU of LCMV Armstrong. Animal experiments were conducted in accordance
with Emory University IACUC protocols.
FACS Analysis and Sorting
Cells were stained as described previously (Youngblood et al., 2011) with
fluorochrome-conjugated antibodies (purchased from BD, eBiosciences,
BioLegend, Vector Laboratories, and Invitrogen). A three-step CXCR5
staining was performed as described by Johnston et al. (2009) by using
purified rat anti-mouse CXCR5 (BD), a secondary Biotin-SP-conjugated
Affinipure F(Ab’)2 Goat anti-rat IgG (Jackson Immunoresearch) and finally
with streptavidin-APC or streptavidin-PeCy7 (Invitrogen). For Bcl6 and T-bet
staining, cells were first stained for surface antigens, followed by permeabili-
zation, fixation, and staining by using the Foxp3 Permeabilization/Fixation
Kit and protocol (eBioscience). Intracellular cytokine staining was done by
standard techniques following 5 hr stimulation with GP61–80 peptide (Murali-
Krishna et al., 1998). Cell sorting was performed by using a FACS Aria II
(BD), and flow cytometry data were collected on a FACS Canto II (BD).
FACS data were analyzed by using FlowJo software (TreeStar).816 Immunity 38, 805–817, April 18, 2013 ª2013 Elsevier Inc.Microscopy
Spleens were frozen in OCT compound (Fisher Scientific, Waltham, MA) and
sectioned. Sections were fixed in cold acetone for 10 min, dried, and stained
with the indicated antibodies. Images were acquired using a Zeiss Axioskop 2
Plus microscope with 103/0.25 and 203/0.50 (magnification/aperature) ob-
jectives and a Zeiss Axiocam MRc5 camera. Image overlays were performed
with ImageJ software (National Institutes of Health [NIH], Bethesda, MD).
RNA Isolation and Microarray Analysis
RNA from sorted cells was purified (QIAGEN), linearly amplified (NuGEN),
and hybridized to Affymetrix mouse 430 2.0 arrays (Memorial Sloan-Kettering
Cancer Center, Genomics Core Facility). Gene pattern 3.4 and the associated
modules were used to analyze the microarray data. Gene set enrichment anal-
ysis (GSEA) was performed as described previously (Subramanian et al., 2005).
Genomic DNA Methylation Analysis
Bisulfite modification of genomic DNA from FACS purified cells was performed
using the Zymo Research EZ DNA methylation kit. Bisulfite modified DNA was
PCR amplified with locus-specific primers (Table S2) as previously described
(Youngblood et al., 2010).
Statistical Analysis
All experiments were analyzed using Prism 4. Statistically significant p values
of <0.05 are indicated and were determined by using a two-tailed unpaired
Student’s t test.
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